Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

Ricardo D. Parrondo; Betsy R. LaPlant; Jamie Elliott; Andre Fernandez; Caitlin J. Flott; Diedre Arrington; Dustin Chapin; Jade Brown; Saurav Das; Vivek Roy; Asher A. Chanan-Khan; Sikander Ailawadhi

doi:10.1038/s41408-024-01134-3

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

Ricardo D. Parrondo
, Betsy R. LaPlant
, Jamie Elliott
, Andre Fernandez
, Caitlin J. Flott
, Diedre Arrington
, Dustin Chapin
, Jade Brown
, Saurav Das
, Vivek Roy
, Asher A. Chanan-Khan
, Sikander Ailawadhi

Hematology / Oncology / Cancer Center / Breast Clinic

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	152
Journal	Blood cancer journal
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41408-024-01134-3
State	Published - Dec 2024

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-024-01134-3

Cite this

@article{0be9f41549a348debfd346fc09e2d317,

title = "Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma",

author = "Parrondo, \{Ricardo D.\} and LaPlant, \{Betsy R.\} and Jamie Elliott and Andre Fernandez and Flott, \{Caitlin J.\} and Diedre Arrington and Dustin Chapin and Jade Brown and Saurav Das and Vivek Roy and Chanan-Khan, \{Asher A.\} and Sikander Ailawadhi",

year = "2024",

month = dec,

doi = "10.1038/s41408-024-01134-3",

language = "English (US)",

volume = "14",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

AU - Parrondo, Ricardo D.

AU - LaPlant, Betsy R.

AU - Elliott, Jamie

AU - Fernandez, Andre

AU - Flott, Caitlin J.

AU - Arrington, Diedre

AU - Chapin, Dustin

AU - Brown, Jade

AU - Das, Saurav

AU - Roy, Vivek

AU - Chanan-Khan, Asher A.

AU - Ailawadhi, Sikander

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85203419966

UR - https://www.scopus.com/pages/publications/85203419966#tab=citedBy

U2 - 10.1038/s41408-024-01134-3

DO - 10.1038/s41408-024-01134-3

M3 - Letter

C2 - 39237502

AN - SCOPUS:85203419966

SN - 2044-5385

VL - 14

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 152

ER -

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this